Anbc, Inc.(OTC) SYUP

Anbc, Inc. is a Shanghai-based company specializing in the development, manufacturing, and distribution of traditional Chinese herbal remedies and innovative biological pharmaceuticals. The diverse product portfolio addresses various health concerns, catering to a growing market in the People's Republic of China.

Products and Services

• Traditional Chinese herbal remedies for immune support and vitality
• Biological pharmaceuticals targeting kidney, liver, and respiratory health
• Various syrups for treating coughs, flu symptoms, and other ailments

Growth Outlook

• Increasing demand for herbal remedies in China supports market expansion
• Focus on innovative pharmaceuticals aligns with healthcare trends
• Strategic partnerships may enhance distribution capabilities

Financial Highlights

• TTM revenue of $1,000, indicating potential for growth
• Net profit margin of 41.14% reflects operational efficiency
• Current ratio of 2.75 suggests strong liquidity position

Anbc, Inc. operates within the Drug Manufacturers - Specialty & Generic industry, leveraging its expertise in both traditional and modern medicine. The company's product offerings, including Qilisheng and various herbal syrups, cater to a wide range of health needs, positioning it well in a growing market. The recent financial data indicates a promising trajectory, with a notable net profit margin and a solid current ratio, suggesting effective management of resources. The growth outlook remains positive, driven by increasing consumer interest in herbal remedies and potential strategic partnerships that could enhance market reach.